Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Klatskin Tumor 1 Carcinoma, Hepatocellular 1

Interventions

Specimen Handling 3 Oxaliplatin 3 Magnetic Resonance Spectroscopy 3 Fluorouracil 3 Radiosurgery 2 Liver Transplantation 2 Gemcitabine 2 Cisplatin 2 Biopsy 2 tislelizumab 1 sacituzumab govitecan 1 gemcitabine-oxaliplatin regimen 1 fludarabine 1 dehydroftorafur 1 binimetinib 1 Tegafur 1 S 1 (combination) 1 Pancreatic Hormones 1 Leucovorin 1 Hydroxychloroquine 1 Cyclophosphamide 1 Cholangiopancreatography, Endoscopic Retrograde 1 Capecitabine 1 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Klatskin Tumor × Pancreatic Hormones × 1 year × Clear all

NCT06850753 2025-08-21

SURE-LT

Oslo University Hospital

Phase NA Recruiting

Gastrointestinal

Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡